Trials / Completed
CompletedNCT03749408
Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain
Effect of Addition of 0.5 Mol/L Mannitol to 0.5% Bupivacaine on IANB Success and Post-endodontic Pain in Mandibular Molars With Irreversible Pulpitis: A Randomized Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 17 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Inferior alveolar nerve block using either 0.5% bupivacaine alone or in addittion to mannitol in patients with irreversible pulpitis in mandibular molars.
Detailed description
Patients with irreversible pulpitis in mandibular molars will be selected according to the eligibility criteria and patients are then randomized to either using 0.5% bupivacaine alone or in addition to mannitol. Anesthetic success and postoperative pain will then be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bupivacaine plus mannitol | local anesthesia |
| DRUG | bupivacaine alone | local anesthesia |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2018-11-21
- Last updated
- 2018-11-23
Source: ClinicalTrials.gov record NCT03749408. Inclusion in this directory is not an endorsement.